NeuroMetrix Reports High Level of Media Coverage for Quell in First Quarter

BOSTON–(BUSINESS WIRE)–$NURO #NeuroMetrix–NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media
attention focusing on the company’s innovative Quell®
Wearable Pain Relief Technology. Highlights include:

“We are pleased with the increased attention Quell has attracted in the
media during the first quarter of 2016,” said Frank McGillin, Senior
Vice President and General Manager, Consumer of NeuroMetrix. “We are
proud to see Quell reviewed in top tier media outlets such as Newsweek
and Consumer Reports, and continued coverage in the Boston Globe.”

About Quell Wearable Pain Relief Technology

Quell is an easy-to-use, over-the-counter device for relief of chronic
pain. This wearable device utilizes NeuroMetrix’s patented technology to
provide widespread pain relief. In a recent clinical study, Quell
improved chronic pain in 81% of participants. Quell is currently
available through select healthcare professionals, retailers and online

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit


NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer